The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions
Year of publication: |
January 2017
|
---|---|
Authors: | Bognar, Katalin ; Romley, John A. ; Bae, Jay P. ; Murray, James ; Chou, Jacquelyn W. ; Lakdawalla, Darius |
Published in: |
Journal of health economics. - Amsterdam [u.a.] : Elsevier, ISSN 0167-6296, ZDB-ID 625797-5. - Vol. 51.2017, p. 1-12
|
Subject: | Surrogate endpoints | Drug approval | Drug reimbursement | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Theorie | Theory |
-
García-Alonso, María del Carmen, (2008)
-
Sundmacher, Torsten, (2006)
-
Dealing with excessive off-label drug use : liability vs. patent prolongation
Felder, Stefan, (2009)
- More ...
-
Public-private partnership as a path to affordable healthcare in emerging markets
Chou, Jacquelyn W., (2015)
-
An optimal voting procedure when voting is costly
Bognar, Katalin, (2015)
-
A conversational war of attrition
Meyer-ter-Vehn, Moritz, (2018)
- More ...